Fortive Corp stock (US34959J1088): Argus upgrades to Buy with $68 target

Argus Research upgraded Fortive Corp (FTV) to Buy from Hold on May 11, 2026, setting a $68 price target as shares trade around $60.70.

Fortive Corp (FTV) received a rating upgrade from Argus Research on May 11, 2026, moving from Hold to Buy with a price target of $68.00, according to GuruFocus as of May 11, 2026. The stock traded at $60.70 recently, implying upside potential from current levels amid strong fundamentals reflected in its GF Score of 80/100.

As of: 12.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Fortive Corp.
• Sector/industry: Industrial technology
• Headquarters/country: United States
• Core markets: North America, Europe, Asia
• Key revenue drivers: Precision instruments, automation, software
• Home exchange/listing venue: NYSE (FTV)
• Trading currency: USD

Fortive Corp: core business model

Fortive Corp designs, develops, and manufactures professional and engineered products, software, and services for a range of industries including manufacturing, utilities, healthcare, and transportation. The company operates through three main segments: Intelligent Devices, Precision Technologies, and Advanced Healthcare Solutions, according to its investor relations site investors.fortive.com as of May 2026. This diversified portfolio allows Fortive to serve critical applications in test and measurement, automation, and healthcare diagnostics.

Headquartered in Everett, Washington, Fortive focuses on recurring revenue streams from software subscriptions and services, which provide stability amid cyclical industrial demand. Its brands like Fluke and Tektronix are leaders in electrical testing and precision measurement tools used globally.

Main revenue and product drivers for Fortive Corp

Fortive's revenue is driven by demand for test, measurement, and automation solutions, with Intelligent Devices contributing significantly through products like the new Fluke FEV500 for EV charger testing announced recently, per StockTitan as of May 2026. Precision Technologies focuses on sensors and flow measurement, while Advanced Healthcare grows via imaging and diagnostics.

Over the past six months ending May 2026, shares rose 15.8% to $60.25, outperforming the S&P 500 by 7.9%, fueled by solid quarterly results, according to Barchart as of May 2026. The stock trades at 19.9x forward P/E, reflecting market expectations for continued growth.

Industry trends and competitive position

The industrial technology sector benefits from automation and electrification trends, particularly in EVs and renewables, where Fortive's Fluke tools address predictive maintenance needs. A May 7, 2026, industry survey highlighted doubling adoption of such technologies, boosting Fortive's outlook per StockTitan.

Why Fortive Corp matters for US investors

Listed on NYSE as FTV, Fortive offers US investors exposure to industrial tech with strong North American revenue and ties to US manufacturing resurgence. Its focus on software-enabled devices aligns with tech-driven efficiency gains relevant to S&P 500-linked portfolios.

Conclusion

Fortive Corp's recent analyst upgrade by Argus Research to Buy with a $68 target underscores its solid positioning in industrial tech amid positive share performance and product innovations like the Fluke FEV500. While trading near fair value per some metrics, ongoing trends in automation and EV infrastructure support its relevance. Investors track upcoming earnings and market dynamics for further developments.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.